Interface Analysis is recruiting individuals who have been diagnosed with Multiple Sclerosis to participate in a research study in May at our facility in Cupertino, CA. All of our studies are non-invasive, so you will not be asked to take any new medications. You will be paid to participate!
We will be conducting a 60-minute study with indivduals who currently take Copaxone using the Autoinject 2 autoinjector.
The study will take place the week of Monday, May 9th (schedule is still under construction). For participating in the 60-minute session you will be paid $120!
To qualify for this study, you must:
Have been diagnosed with multiple sclerosis (MS)
Currently take Copaxone using the Autoject 2 injector
Bring in your Autoject 2 device (no medication needed).
Be able to walk up a flight of stairs on your own (our offices are located on the 2nd floor and unfortunately there is no ramp or elevator in the building).
If you are interested in participating, please contact us via email at iaa_research@yahoo.com, or via phone at 408-834-8443. Please refer to the "Autoject2 Study" when contacting us, and leave your name and a daytime phone number that we can reach you on. We look forward to hearing from you!
Please pass word of our study to other MS patients you may know who qualify for this study (by forwarding this posting, or by having them email us directly with their contact information).
Thank you in advance for your help!
Thank you!
Interface Analysis
www.interface-analysis.com
Twitter: @IAAresearch
Research Study -Copaxone Autoject 2 Users -60 minutes - $120
A board to discuss the Multiple Sclerosis modifying drug Copaxone
- IAAresearch
- Newbie
- Posts: 2
- Joined: Mon Jan 18, 2010 3:00 pm
- Contact:
Jump to
- Multiple Sclerosis
- ↳ General Discussion
- ↳ Introductions
- ↳ Drug Pipeline
- ↳ Regimens
- ↳ Undiagnosed
- ↳ MS Etiology and Pathogenesis
- Treatments
- ↳ Chronic Cerebrospinal Venous Insufficiency (CCSVI)
- ↳ Low Dose Naltrexone
- ↳ Tysabri (Antegren, Natalizumab)
- ↳ Copaxone
- ↳ Glatopa
- ↳ Avonex
- ↳ Rebif
- ↳ Betaseron
- ↳ Plegridy
- ↳ Novantrone
- ↳ Aimspro
- ↳ Diet
- ↳ Stem Cells
- ↳ Antibiotics
- ↳ Campath (Lemtrada, Alemtuzumab)
- ↳ Gene Therapy
- ↳ Natural Approach
- ↳ Biotin (Qizenday, Cerenday, MD1003)
- ↳ Coimbra High-Dose Vitamin D Protocol
- ↳ Statins
- ↳ Tcelna (Tovaxin)
- ↳ Revimmune (Cyclophosphamide, Cytoxan)
- ↳ Medical Devices
- ↳ Rituxan (Rituximab)
- ↳ Ocrevus (Ocrelizumab)
- ↳ Kesimpta (Ofatumumab)
- ↳ Briumvi (Ublituximab-xiiy)
- ↳ General Medications
- ↳ Tecfidera (BG-12, Dimethyl fumarate)
- ↳ Vumerity (Diroximel fumarate)
- ↳ Bafiertam (Monomethyl fumarate)
- ↳ Gilenya
- ↳ Aubagio (Teriflunomide)
- ↳ Mayzent (Siponimod)
- ↳ Zeposia (Ozanimod)
- ↳ Ponvory (Ponesimod)
- ↳ Mavenclad (Cladribine)
- ↳ Ampyra (Dalfampridine)
- ↳ Medical Marijuana
- ↳ Sativex
- ↳ Chiropractic Treatment
- Life
- ↳ Daily Life
- ↳ Veterans and MS
- ↳ Trigeminal Neuralgia in MS
- ↳ Reading Nook
- ↳ Humor
- ↳ Shopping
- ↳ Friends and Family
- ↳ Mental & Spiritual Health
- ↳ Exercise and Physical Therapy
- ↳ Under 25 with MS
- ↳ MS in the Golden Years
- ↳ Parenting Kids With MS
- ↳ Parents with MS
- ThisIsMS.com
- ↳ Site Support
- ↳ Suggestions